
The current study was conducted to demonstrate that zzso zzso for upper and lower zzso deep vein zzso is equally safe in patients with and without zzso 

A retrospective cohort of consecutive patients with acute zzso or zzso deep vein zzso treated with zzso zzso was zzso zzso characteristics and clinical outcomes were compared between patients with cancer and without zzso 

zzso zzso was used to treat 202 limbs in 178 patients (75 limbs in 61 cancer patients and zzso limbs in 117 patients without zzso The mean treatment duration for patients with cancer zzso zzso zzso zzso and without cancer zzso zzso zzso zzso was similar zzso zzso zzso zzso zzso achieved grade III zzso zzso in a similar proportion of cancer patients zzso of 75 zzso zzso and patients without cancer (82 of zzso zzso zzso P zzso zzso Grade II zzso zzso also was achieved in equal numbers of patients with (20 of 75 zzso zzso and without cancer zzso of zzso zzso zzso P zzso zzso Three cancer patients zzso and four zzso patients zzso experienced major bleeding during zzso zzso zzso zzso zzso Pulmonary embolism occurred in zzso (1 of zzso of cancer patients and in zzso (2 of zzso of patients without cancer zzso zzso zzso during zzso zzso Patients aged zzso or zzso years had an increased risk of major zzso 

zzso zzso zzso is equally safe for patients with and without cancer who have acute symptomatic deep vein zzso 

